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‘Gene’ has become a vague and ill-deﬁned concept. To set
the stage for mathematical analysis of gene storage and
expression, we return to the original concept of the gene as
a function encoded in the genome, basis of genetic analysis,
that is a polypeptide or other functional product. The
additional information needed to express a gene is
contained within each mRNA as an ensemble of signals,
added to or superimposed onto the coding sequence. To
designate this programme, we introduce the term ‘genon’.
Individual genons are contained in the pre-mRNA forming
a pre-genon. A genomic domain contains a proto-genon,
with the signals of transcription activation in addition
to the pre-genon in the transcripts. Some contain several
mRNAs and hence genons, to be singled out by RNA
processing and differential splicing. The programme in the
genon in cis is implemented by corresponding factors of
protein or RNA nature contained in the transgenon of the
cell or organism. The gene, the cis programme contained in
the individual domain and transcript, and the trans pro-
gramme of factors, can be analysed by information theory.
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Introduction
What is a ‘gene’? Surprisingly, in the world of biology and
genetics there is no longer a straightforward answer (cf.
Pearson, 2006). For instance, Snyder and Gerstein (2003)
deﬁne a gene as ‘a complete chromosomal segment respon-
sible for making a functional product’ and then discusses ﬁve
criteriaforidentifyinggenesintheDNAsequenceofagenome.
The most common feeling is that it should be a piece of nucleic
acid. At the onset of molecular biology (Benzer, 1959), the
signiﬁcance of the term gene was clear: it was the unit of
function identiﬁed by genetic methods, as colours of ﬂowers,
theshapeofawing,numberandshapeofbacterialcolonies on
a Petri dish. This analysis had nothing to do with DNA nor
RNA but functions exclusively. According to current insight in
molecular biology, theonly meaningful conception of a gene is
the one of a functional and not of a hereditary unit (see for
example Brosius, 2006).
The concept of the cistron (contiguous genomic elements
acting in cis, essentially the protein coding sequence)
introduced by Benzer (Benzer, 1959,1961; Benzer and
Champe, 1961) and extended by Jacob and Monod (1961)
related the gene to an un-interrupted piece of DNA, able to
complement a function in a cis/trans test. The equation
function¼gene¼polypeptide¼continuous piece of DNA¼
cistron seemed acceptable in ﬁrst approximation. However,
when several genes were found to constitute an ‘Operon’
(Jacob and Monod, 1961), representing a programme of gene
expression, other problems arose with the introduction of the
notionofregulatorygenes;forinstance,thegenecodingforthe
lac-repressor protein. The latter has to attach to the operator, a
DNA sequence placed in cis upstream of the genes in the
operon. The operator—is it (part of) a ‘gene’? The lac function
is based on operator action, thus it is related to the phenotype;
but the lac repressor gene is not part of the cistrons controlled
by the operator.
With the advent of eukaryotic molecular biology, the
problem of deﬁning the gene became even more complicated.
In eukaryotes, the tight physical complex linking transcription
and translation in bacteria does not exist; the polyribosomes
are removed from the DNA, which is stored away in the
nucleus. As a consequence, the dimensions of space and time
enteredgeneexpression(seeFigure1,inset A;andTheCascade
of Regulation (Scherrer and Marcaud, 1968)) and new types of
controls had to be considered, in particular at the level of the,
by now, autonomous messenger RNA (mRNA). There is an
untranslated region (UTR) of about 50–250nt (Gray and
Hentze, 1994; Hess and Duncan, 1996) preceding the coding
sequence in the mRNA, and at the end of the mRNA chain the
30-side UTR which, surprisingly, in some genes (for example,
the Prion mRNA) grew to become longer than the coding
sequence. Being contiguous and in cis, upstream and down-
stream of the coding sequence, such a construct of nature did
not ﬁt the original concept of the gene.
AnotherproblemarosewiththeobservationthatmRNAwas
able to form mRNA–protein (mRNP) complexes. It was found
that speciﬁc proteins recognise and attach to speciﬁc sequence
motifs along the mRNA chain, and not only in the UTRs, but
right inside the coding sequence, as could be proven early on
for globin mRNAs (Dubochet et al, 1973). This indicated that,
superimposed onto the coding sequence, there must exist
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of interaction.‘Free’ mRNPs, found in vivo outside the transla-
tion machinery of the polyribosomes, are not translatable
invitro,unlessmostofthemRNPproteinsareremoved(Civelli
et al, 1980); these proteins seem hence to relate to repression.
RNPs may also form higher order complexes (cf. review
in Dreyfuss et al, 2002), assembled by interaction of (pre-)
mRNA with proteins and protein complexes (De Conto et al,
1999), or cellular structures, such as, the cytoskeleton (Singer,
1992); they constitute part of the backbone of the nuclear
matrix (De Conto et al, 2000; Razin et al, 2004; Ioudinkova
et al, 2005).
A fatal blow to the original gene concept came with the
observation of giant precursor RNA and their processing
(Perry, 1962; Scherrer and Darnell, 1962; Georgiev et al, 1963;
Scherrer et al, 1963; Perry et al, 1964) (review in (Scherrer,
2003)). After the experimental observation of pre-mRNA
(Scherrer et al, 1970), the discovery of ‘splicing’ (Berget
et al, 1977; Chow et al, 1977) implied the fragmentation of the
coding sequence at the genomic level: in most cases, only
fragments and not intact genes are stored in DNA. According
to the original genetic deﬁnition of the gene, and the cistron
concept,thisindicatedthat, eachtimeitneedstobeexpressed,
the gene has to be created from its parts encoded in the DNA
(Figure 1, inset A; cf. disc. in Scherrer, 1980,1989; Brosius and
Gould, 1992). Interestingly, the occurrence of differential
splicing and, as a consequence, the fact that the same DNA
domain can contain the information for different genetically
identiﬁable functions, indicated clear separation of the gene as
a function from its genomic counterpart in the form of DNA,
transmitted from generation to generation. Accordingly, these
two matters might also be separated conceptually and in
terminology.
The discovery of ‘polycistronic’ giant RNA (Scherrer et al,
1966) (review in Scherrer, 2003) and the formulation of the
pre-mRNA concept (Scherrer et al, 1966; Scherrer and
Figure 1 The Cascade of Regulation (Scherrer, 1967,1980): The information content of the zygotic genome is gradually reduced to that expressed in a differentiated
cell. In Homo sapiens an estimated 500000 polypeptide-genes are reduced to a few hundred in gradual steps; as few as 3 genes may account for up to 90% protein
output, as is the case in red blood cells. The Holo-Cascade (not shown) includes additional steps, leading upstream from the information content of an entire species to
that of populations and individuals, and downstream from the polypeptide to the assembled protein including all post-translational modiﬁcations (Scherrer, 1980). Under
thedirectionoftheholo-genonandholo-transgenon,thegenomicinformationisreducedbyDNArearrangementstothatofanindividualcell,andthenbyindividualsteps
to the expression of an individual function, as shown here and outlined in the text. These may include the following (1–2) chromatin modiﬁcation and activation
(protogenon-dependent); (3) transcription and formation of pre-mRNP (pre-genon); (4–6) gradual processing and splicing (pre-genon); (7) export and formation of
cytoplasmicmRNP(genon); (8–9)activation(de-repression) ofmRNP(genon);(10)translationofmRNA(genon)followedbypeptide formation(genon hasexpired)and
gene expression. (A) The spatial transfer of a genomic transcript to RNA processing centres (Iarovaia et al, 2001) and the nuclear periphery and (speciﬁc sites in) the
cytoplasm (De Conto etal, 1999) induces a delay and, hence, a vector intime. Processingand transport steps may be temporarily interrupted, andlead toconsiderable
delay ofexpression (up to 30years inthe case ofhistone mRNA inhumanoocytes), andthe constitution of ‘peripheral memories’ (Scherrer, 1974,1980), fromwhere the
gene will be created and/or expressed, eventually. These may be in the form of unspliced (fragmented genes) or ﬁnally spliced pre-mRNPs, cytoplasmic mRNPs or
miRNA complexes. (B) The genomic information being gradually reduced along the Cascade, information from the external space of the cell and organism plays a
gradually increasing function. Highest at the periphery, concerning for example all cell-surface receptor functions, some external instructions may reach the genomic
DNA to bring about a physiologic change. This can be conceived as an ‘exo-cascade’ as proposed here, ‘inﬁltrating’ the ‘endo-cascade’ of gene expression.
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impossible to concentrate into a single term all types of
information involved in the expression of a single genetic
function. To lead out of the actual confusion we suggest to
break up the process of gene expression into its basic
mechanistic, and thus logical units, namely gene function on
the one hand and the mechanisms of storage and expression
on the other. In this process, one is led to propose new
concepts and terms that give precise deﬁnitions to compre-
hend gene expressionin terms of Molecular Biology, and make
it possible to analyse gene storage and expression in terms of
information processing. Our intention is to present here a
functional and information theoretic analysis of gene storage
and expression.
Gene deﬁnition, expression and
regulation
The basic system of information involved in gene expres-
sion, and the one most easily deﬁned, is the coding
sequence contained within the mRNA and its counterpart
after translation, the nascent polypeptide. This leads back to
the original deﬁnition of the gene, the unit of genetic
function and analysis as used by Mendel and Morgan. It
implies the polypeptide chain as the underling basic unit of
function, or its equivalent, the uninterrupted nucleic acid
stretch of the coding sequence, the ‘cistron’ of Benzer
(1959). This nucleic acid stretch emerges at the level of the
mRNA in eukaryotes, and in most cases is not present at the
DNA level as an uninterrupted sequence. In the discussion
below, this should be the unique and exclusive deﬁnition
and meaning of the term ‘gene’.
Attached to such a gene is the ‘history’ of its ‘creation’ from
pieces in the genome before its expression; in other words,
along with the transcript comes a programme that secures the
formation of the mRNA and its expression in time and space.
This programme will be conceptualised as the genon. Within
this programme, two kinds of elements of control may be
distinguished: (1) the cis-acting signals, which form (oligo-)
sequence motifs contained in the same strand of DNA or RNA
as the fragments of the coding sequence, and (2) the trans-
acting factors which act on the signals placed in cis. Both
participate in the programme that secures the generation of
the gene, in the cellular space and in time, through the many
steps of gene expression.
The genon concept concerns gene expression at large. Some
genetic information, however, is only indirectlyrelatedto gene
expression, like the 3D organisation of DNA and chromatin
(see the Uniﬁed Matrix Hypothesis (Scherrer, 1989), and the
recent observation of ‘3D-gene regulation’ (Spilianakis et al,
2005)). Furthermore, epigenetic mechanisms of gene expres-
sion and transmission modify the genon in cis and its
precursors at DNA level; the genon is, thus, ﬂexible and not
a rigid programme. Quite in general, we consider here only
regulation directly related to gene expression, leaving out
other types of signalling and metabolic controls. These
points will be detailed in a more extensive analysis of gene
expression and the genon concept (Scherrer and Jost,
submitted to Th Biosci).
Types of information related to gene
expression and regulation
Before developing the genon concept, we describe the types of
information involved in gene expression, as well as the nature
of the products. Gene expression results in the synthesis of
products that may be either protein or RNA in nature; these
products may carry out a given structural or enzymatic
function, or may control the gene expression pathway in a
mechanistic or regulative manner. Accordingly, we should
make a distinction between protein genes (P-genes) and RNA
genes (R-genes) on the one side, and between structural genes
(s-genes) and controlling genes (c-genes). Combined, we have
sP-genes and sR-genes as well as cP-genes and cR-genes.
The P-gene is the equivalent of the triplet-based
coding sequence in the mRNA
The protein-coding sequence is the equivalent of the gene in
the mRNA, being deﬁned by genetic analysis carried out at the
levelofthephenotype.Theoutcomeofthisanalysisconstitutes
the genotype as the ensemble of deﬁned functions, which may
be transmitted by heredity. Such physiological functions are
based on the expression of an ensemble of unit functions. The
unit function, subject to mutation, is carried by the polypep-
tide in its nascent form. The actual function is exerted in
general by a quaternary protein or RNP complex, which may
integrate several identical and/or different proteins, possibly
modiﬁed chemically, as well as low-molecular-weight cofac-
tors of organic or inorganic chemical nature.
The unit of a coding sequence is the triplet of nucleotides
which,accordingtothegeneticcode,directsduringtranslation
of an mRNA the choice of a given anticodon carried by a given
tRNA. Owing to the degeneracy of the code, incorporation of
an identical amino acid may be directed by different triplets.
As a consequence, according to the triplet chosen for a given
amino acid, at the level of the mRNA a different nucleotide
sequence is formed. The resulting different secondary struc-
ture of the nucleic acid may be ‘recognised’ by proteins
interacting with the mRNAs, or by small interfering RNAs
(siRNAs)/microRNAs(miRNAs)controllingRNAinterference
(RNAi).
Structural protein genes (sP-genes)
By deﬁnition, structural protein genes contribute to cellular
structure and function either directly or via enzymatic
activities. They may constitute the building blocks of the
nuclear and plasmatic membranes, the endoplasmic reticu-
lum,thenuclearmatrixandthecytoskeleton.Asenzymesthey
governtheintermediarymetabolismaswellasprotein,RNAor
lipid biosynthesis and degradation. The proteins acting as the
mechanistic and enzymatic carriers of the system of protein
biosynthesisdonot discriminate among speciﬁc types of DNA,
pre-mRNA or mRNA. Among them are, for example, the RNA
polymerases, the non gene-speciﬁc splicing factors, the
nonspeciﬁc transport factors such as ‘exportin’ (Rodriguez
et al, 2004; Kutay and Guttinger, 2005) or NLS (nuclear
localisation signal) binding to RNA sequences (Rodriguez
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the proteins binding the CAP motif on the 50-start or the
poly(A) tail of the mRNA.
Regulatory protein genes (cP-genes)
Regulatory protein genes control gene expression from
transcription to translation; they may function as repressors
or activators of transcription, or act at post-transcriptional
levels by interaction with pre-mRNA and mRNA. Four sets of
such regulatory nucleic acid binding proteins (NABPs) can be
distinguished: (1) the transcription factors of non-histone type
as well as the histone- and DNA-modulating factors, which
control local remodelling of chromatin, regulating access
of the transcription machinery to DNA, (2) The nuclear pre-
mRNA binding proteins (pre-mRNPs or hnRNPs), which
interact, in speciﬁc sets, with given types of pre-mRNA, in
statu nascendi as well as at the level of the nuclear matrix;
there are several hundreds of relatively acidic proteins bound
in part by hydrophobic bonds, and relatively fewer (some
dozens) basic proteins bound by ionic interaction (the
‘histone-type’ of pre-mRNP proteins) (Maundrell et al,
1979). (3) The cytoplasmic proteins binding in variable sets
the non-translated mRNAs (‘silent’ or (ribosome-)‘free’
mRNPs); these proteins bind in general by hydrophobic
interaction, they act positively in guiding the cytodistribution
of mRNA, and negatively as cytoplasmic repressors (Maun-
drell et al, 1979). (4) The prosome particles (also known to
constitute the core of the 26S proteasomes), a population of
protein complexes built of 2   14 subunits in variable
composition (Schmid et al, 1984), which bind on one side to
chromatin, pre-mRNA and cytoplasmic repressed mRNA
(review in Scherrer and Bey, 1994), and on the other to the
nuclear matrix (De Conto et al, 2000; Ioudinkova et al, 2005)
and the cytoskeleton (Arcangeletti et al, 2000).
Among these cP-gene products, two types can be distin-
guished: (1) those that act on speciﬁc individual genons in
mRNAs, thus regulating the expression of speciﬁc genes, and
(2) those that control the expression of whole sets of genes or
gene families. Among the latter are, for instance, some types
of transcription and translation factors.
Structural RNA genes (sR-genes)
The most important member of this class of RNA is the
ribosomal RNA (rRNA), which serves as the scaffold of
ribosomal subunits by organising the sequential alignment of
ribosomal proteins (Scheer and Hock, 1999; Tschochner
and Hurt, 2003). In addition, ‘rRNA is a ribozyme’ (Steitz
and Moore, 2003).
The metabolic precursor of rRNAs (Perry, 1962; Scherrer
and Darnell, 1962; Scherrer et al, 1963) in the small (16S and
18S rRNA, respectively in prokaryotes and eukaryotes) and
large (23S/28S rRNA) ribosomal subunits is the nascent pre-
rRNA (45S in eukaryotes), which functions in a similar way to
align not only the proteinsending up in the ﬁnal ribosome, but
also other proteins that, in eukaryotic cells, never leave the
nucle(ol)us. The latter proteins play a structural role in
ribosome biosynthesis and the nucleolar dynamic architec-
ture; pre-ribosomes form the ﬁbrillar centre of the nucleolus,
whereas the ﬁnal ribosomal subunits constitute its granular
zone (Scheer and Benavente, 1990).
Regulatory RNA genes (cR-genes)
Among the regulatory RNAs operating in gene expression we
have to distinguish those that act on many types of (pre-)
mRNAwithoutindividualselection,fromthosethatselectively
recognise and control individual types of mRNA and
pre-mRNA in a sequence-speciﬁc manner. The latter allow
forstrictrecognitionandcontrolofindividualgeneexpression,
whereas the former RNA may discriminate among classes but
not between individual mRNAs.
Non-discriminating cR-genes
The moststraightforwardexampleof such RNAarethetRNAs,
which select individual triplets in the coding sequence.
Concentration and availability of speciﬁc types of tRNA
corresponding to types of (degenerate) triplets, or the many
chemicallymodiﬁed tRNAtypes may inﬂuenceandcoordinate
the expression of classes of mRNA. Similar limited regulatory
function is exerted by the U-type RNAs involved in splicing
(Valadkhan, 2005; Will and Luhrmann, 2005) and the
snoRNAs(smallnucleolar RNA), oftenencodedwithin introns
of pre-mRNA (Filipowicz and Pogacic, 2002), which guide
RNA modiﬁcation (Dennis and Omer, 2005).
Discriminating cR-genes: siRNA and miRNA
The advent of RNAi marked the unexpected discovery of
natural antisense transcripts, which silence sequence-speciﬁc
mRNA (see review in Sontheimer, 2005). Although still
controversial, it is not excluded that this type of post-
transcriptional regulation may occur also at pre-mRNA level
in the nucleus (Matzke and Birchler, 2005). The basic
mechanism of RNAi is the synthesis of, by an RNA-dependent
RNA polymerase and an RNA replicase, double-stranded RNA
copies of target RNAs, in particular mRNA. From such double-
stranded RNA, several hundred basepair long, short 21–25nt-
long fragments are cut out within the RISC RNA–protein
complex. Such siRNA induces destruction of the target mRNA
after sequence-speciﬁc hybridisation, whereas the miRNAs,
often encoded in introns, silence temporarily a given mRNA.
SiRNAandmiRNAformdistinctsiRISCandmiRISCcomplexes
(for a recent review see Sontheimer and Carthew, 2005).
Basic principles and development of the
genon concept
The process of gene expression entails many steps within ‘the
Cascadeof Regulation’ (Scherrerand Marcaud, 1968; Scherrer,
1967, 1974, 1980), which reduce the genomic information to
that of a gene in a stepwise manner. These include chromatin
modiﬁcation and activation, transcription and RNP formation,
processing and transport of the pre-mRNA, formation
and export of the mRNA to the cytoplasm, activation (or
de-repression) of mRNA and, ﬁnally, translation (see Figure 1;
Scherrer and Jost, submitted to Th Biosci). The cis
programme guiding this process is unique to each distinct
The gene and the genon concept
K Scherrer and J Jost
4 Molecular Systems Biology 2007 & 2007 EMBO and Nature Publishing GroupmRNA and polypeptide to be formed, although the same
signals, in distinct combinations, may be used on the
expression pathways of similar or different genes. To express
this fact, we suggest the term ‘genon’ (contraction of ‘Gene’
and ‘operon’) for the cis-acting programme, associated with a
speciﬁc gene at mRNA level but encoded originally in the
DNA. The ensemble of trans-acting factors bearing on a genon
constitutes the ‘transgenon’ of an mRNA or an ensemble of
mRNA in a cell compartment, a cell or organism. Figure 2
shows the basic propositions of the genon concept.
Genons and transgenons are ﬂexible programmes and may
be modiﬁed without touching the DNA sequence. In cis, the
holo-genon is modiﬁed when somatic or heritable epigenetic
modiﬁcations occur, for example by DNA methylation. In
somaticcells,thetransgenonisconstantlyadapted byaddition
and elimination of factors of genomic or environmental origin
and there are heritable protein and RNA factors involved in
genetic and epigenetic regulation (for recent reviews see
Delaval and Feil, 2004; Peaston and Whitelaw, 2006)).
The genon acting in cis
As deﬁned above, the genon represents a regulatory pro-
gramme superimposed and attached to a given coding
sequence. It is materialised in cis by the ensemble of signals
withinthemRNAprimaryandsecondarystructurethatcontrol
the expression of the coding sequence contained. These
signals (henceforth referred to as ‘oligomotifs’) are either
superimposed onto the coding sequence or materialise within
the mRNA sequence of the 50- and 30-side UTR; the mRNA
sequence carrying a given programme is, therefore, longer
than the coding sequence to which it is attached. In this
manner, a speciﬁc genon in cis is deﬁned for every gene
(Figure 2). Implementation of the genon-programme in cis
is carried out in trans by NABPs on the one side, and by
interfering small RNAs (siRNAs, miRNAs) on the other;
altogether, these factors provide the transgenon the pro-
gramme in trans (see below), corresponding to a given genon
(respectively mRNA).
A polycistronic pre-mRNA and/or a full domain transcript
(FDT) (Broders et al, 1990) might thus carry a ‘Pre-genon’,
controlling in cis one or several coding sequences. It may be
polycistronic (several (fragmented) coding sequences in a
row)orpolygenic,containingthefragmentsofseveralgenesto
be crated by differential splicing.‘Proto-genon’ designates the
signalsofaDNAdomain includingaspeciﬁcpre-genon and,in
addition, the signals for chromatin modiﬁcation and transcrip-
tional activation. Each mRNA produced by alternative splicing
would thus carry a genon as the remaining elements of its pre-
Figure 2 Coding sequence, gene, genon and transgenon: the amino-acid sequence of a polypeptide represents the gene, as the basis of a function; its equivalent at
RNAlevel isthe codingsequencewhichisinserted intothemRNAandframedbythe50-endand30-endUTRs.Inthe latterandsuperimposed ontothe codingsequence
isthegenon,aprogramme incisofsequenceoligomotifs,eventualbindingsitesforregulatoryproteins(orsi/miRNAs—notshown).Theholo-Transgenon ofagiven
cell is constituted by all these factors, which eventually will recognise the oligomotifs (empty coloured circles) in the genon in cis. A subset of factors (ﬁlled circles)
interacting with a speciﬁc mRNA constitute the latter’s Transgenon (PABP: poly(A)-binding protein). If the gene is a functional RNA, the same formalism applies.
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the mRNA, including all cis-acting signals. At the genomic
level, the term ‘holo-genon’ designates the sum of all
(proto-)genons. Figure 3 shows this process from DNA to
mRNA expression.
The concept of the genon relates to the cis programme
directly, and only indirectly to the transgenon, the system of
trans-acting factors. Indeed, each trans-acting factorof protein
or RNA nature is the result of a gene and its own genon.
Implicitinthegenonconceptisthefactthatthereareatleastas
many genes and genons as distinct open reading frames
(ORFs) encoded in the genome. Accordingly, the 36000 or so
genomic domains identiﬁed within the human genome project
(cf. Venter et al, 2001; for more recent estimates, see Pennisi,
2003) would encode about 500000 genes producing as many
polypeptides. The genomic domains emerging, possibly, from
sequence data correspond—by order of magnitude—to the
highest molecular weight transcripts (FDTs) in eukaryots and
to the DNA in loops of lampbrush chromosomes, or in the
chromosome bands of polytene chromosomes of diptera.
Thesewereidentiﬁedasunits oftranscription,and insciaridae
as units of local DNA ampliﬁcation, and cytogenetically as
units of meiotic recombination (cf. discussion in Scherrer and
Marcaud, 1968; Scherrer, 1980,1989; Scherrer and Jost,
submitted to Th Biosci).
The genon and its precursors act at the transcriptional and
post-transcriptional levels and lose their function with mRNA
translation and subsequent degradation. Therefore, we will
not consider here the downstream programmes governing
gene expression post-translationally, or the catabolic aspect of
protein homeostasis. However, most obviously, gene expres-
sion implies control of amounts as well as types of gene
products and, therefore, RNA and protein degradation as well
as biogenesis. This is achievable only by interplay and
coordination of protein biosynthesis and degradation, as
conceivable for example, within the prosome–proteasome
system (Scherrer and Bey, 1994).
The transgenon
The genon in cis as outlined above is materialised by the
ensemble of factor binding sites (‘oligomotifs’) within an
individual mRNA sequence. These sites are recognised by
protein or RNA factors supplied by the programme in trans.
These are available—or not—within the holo-transgenon of
a given cell, nucleus or cytoplasm. We exclude here all
mechanisms directly related to constitutive and basic protein
biosynthesis within the frame of the genetic code, such as the
ribosome and the basic tRNA machinery.
Regulation of transcription, and hence of programmes of
differentiation and physiological change, occurs largely under
the inﬂuence of cell-external factors,constituting some kind of
Exo-cascade (see Figure 1, inset B), which act eitherdirectlyor
via the transgenon.
The genon of an mRNA is, thus, plunged into the pool of
trans-acting factors recognised by the receptor oligomotifs in
cis,‘ﬁshing out’ its speciﬁc transgenon. The presence of these
factors is thus crucial for execution of the expression
programme encoded in the genon in cis. Being automatically
picked-up by the oligomotifs in cis, these factors have a
discriminative regulatory function. Their presence or absence
controls the implementation of the cis programme; further-
more they may be present in active or inactive state. As
proteins are capable of integrating many types of input, small
molecular weight agents may inﬂuence factor–signal inter-
actions either directly or as allosteric effectors.
Nucleic acid-binding proteins as carriers of the
transgenon
A majorpart of the transgenon is constituted byNABPs,which
are produced from cP-genes by the normal mechanisms of
gene expression and regulation by protein biosynthesis. All
types of RNA in the cell are covered by proteins (1:3 ratio
in mRNPs). In the case of mRNA, it was shown by electron
microscopy (Dubochet et al, 1973) that proteins are aligned
along the entire length of the RNA molecules (and it is thus
likely also for pre-mRNA), protecting speciﬁc oligomotifs from
degradation by RNase (Goldenberg et al, 1979). Only in rare
cases the oligonucleotide sequence that binds a given
regulatory protein is known; in addition to the poly(A)-
binding protein (PABP), one might mention, for example, the
IRE-BP (iron response element binding protein), a protein that
binds an oligomotif in the 50-side or 30-side UTRof the mRNAs
for ferritin and transferrin, respectively (Thomson et al, 1999).
These observations indicate that there must be a ‘code’
governing the interaction of a limited number of NABPs in
chromatin and mRNPs, which, in general, are speciﬁcally
DNA- or RNA-binding proteins. However, relatively new data
have conﬁrmed the earlier observation that a given protein
may bind both, DNA and RNA. This was originally observed
for the large T-antigen of SV40 and polyomavirus (Darlix et al,
1984)andmorerecentlyconﬁrmedforaseriesofDNA-binding
MAR proteins, long identiﬁed as hnRNP proteins (von Kries
et al, 1994).
Nucleic acids as carriers of the transgenon
within RNAi
As mentioned above, RNAi represents another mechanism
of post-transcriptional regulation acting on pre-mRNA and
mRNA interacting with the genon in cis. Because this topic is
presently undergoing rapid development, we should defer this
discussion to our forthcoming more extensive analysis
(Scherrer and Jost, submitted to Th Biosci).
Mathematical analysis of genetic
information and gene expression
General considerations
We will go beyond the classical application of information
theory to molecular biology by deﬁning a mathematical
framework that distinguishes the mere coding information
from process and product information contained in the genon
and thus naturally includes gene expression and regulation.
Thus, we will approach here the mathematical analysis of
thegenon,thatistheprogrammegoverningtheexpressionofa
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6 Molecular Systems Biology 2007 & 2007 EMBO and Nature Publishing GroupFigure 3 From DNA to mRNA expression: proto-genon, pre-genon and genon: (1) the genomic domain (line A) with exons (light green) and fragments of coding
sequences (dark green) as well as intra-genic and inter-genic (not shown) DNA, contains instructions for modelling and activation of chromatin; this constitutes the
proto-genon (A0). (2) From these, a pre-mRNA (B) or a FDT with its pre-genon (B0) may spring off. The latter may contain gene fragments subject to differential
splicing; shown is the case of a pre-mRNA containing the two ORFs 1 and 2. (3) After processing and splicing, the two mRNAs are created with their respective genons
and, thereafter, the two gene equivalents, the mRNAs (1) and (2). (4) After translation, peptides 1 and 2 secure two functions. If the gene is a functional RNA, the the
same formalism applies. Inset: To the proto-genon, pre-genon and genon signals (oligomotifs) carrying distinct instructions for speciﬁc steps of processing and gene
expression (left), correspond factors from the transgenon (right), in active or inactive states, which may (or not) implement the corresponding control.
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the ensemble of genon-related signals encoded in DNA and
RNA, and then be extended to trans-programme that is, the—
ratherheterogeneous—ensembleoffactors,providedeitherby
the genome or the environment of cell and organism, which
interact with the signals in cis. The decision-making processes
may be analysed in a different manner, according to whether
the hologenon (all proto-genons encoded in a genome) of an
organism or speciﬁc cell is considered, or the genon of an
individual mRNA. Analysing gene expression by starting at
the DNA level, the ﬁrst decision-making process logically
concerns the ‘immersion’ of a holo-genon in cis into the
population of factors provided by the transgenon of a given
cell, as occurring during the dispersion of sperm DNA (devoid
of any attached protein) into the ooplasm of an egg after
fertilisation. It is simpler, however, to start from the other end,
and ﬁrst consider the immersion of a genon, as present in a
givenmRNA,intothecytoplasmofagivenspecialisedcell.Ina
given cytoplasm, there are only about 500–1000 RNA-binding
protein factors to which a given mRNA may be exposed. This
approach reduces the selection process to the interaction of
such a population of factors with the dozens or so signals in
a given genon. In a ﬁrst step, we consider a theoretically
maximal trans programme, assuming that all possible trans-
factors within a given genome were available to an mRNA; the
decision process in this case would be reduced to the ‘ﬁshing-
out’ bya given mRNAof the factorscorresponding to its genon
in cis (see Figure 2). The constitution of the trans programme
for a speciﬁc cell might be analysed in a further step.
Information theoretic aspects of gene
storage and expression
Information theory, as developed by Shannon, is concerned
with the reduction in uncertainty obtained by receiving a
particular message m drawn from some ensemble W when,
before actually receiving it, one only knows the probabilities
pm of the messages m (which satisfy the normalization
P
mAw
pm¼1). These probabilities may be constructed as relative
frequencies obtained from counting the messages received
in the past. The information gained or, equivalently, the
uncertainty reduced by receiving the actual message then is
quantiﬁed by the entropy
I :¼ 
X
m
pm log2 pmðbitsÞð 1Þ
The simplest nontrivial situation arises when we have only
two messages, each of them occurring with equal probability
1/2.Inthatcase,I¼1(bit).Messageswithprobability¼0donot
contribute, because 0log0¼0, and when one message m is
certain to occur, that is pm¼1, then we gain no information
(1log1¼0) by receiving it because we knew it already before.
In molecular biology as well as in other applications of
information theory, the messages are often sequences S¼(i1,
i2,i3,y,im)composedofsymbolsidrawnfromsomealphabet
A. Each symbol again occurs with some probability pi, and
whenthesymbolsinthesequenceSarechosenindependentof
each other, the probability of that sequence is
Ps ¼ pi1pi2 ...pim ð2Þ
As such, information theory is a formal tool, and for apply-
ing it, we need to specify the ensemble of messages or the
alphabet of symbols. In molecular biology, the symbols
are either nucleotides or amino acids. The former applies
to DNA sequences, which are composed of four nucleotides,
A, C, G and T. When each of them occurs with relative
frequency pi (i¼A,C,G,T), each position contributes an
information of
Inuc ¼ 
X
i¼A;C;G;T
pi log pi bits ð3Þ
In particular, when all pi¼1/4, this information is 2 (bits). For
other values of the pi (still satisfying the normalization P
i¼A,C,G,Tpi¼1), Inuc is smaller. When all positions in a
sequence of a length N are independent, the sequence
information is Iseq¼NI nuc. Sequence correlations, however,
will decrease that information.
The other type of sequences are polypeptides, which are
composedofaminoacids.Thereexist20differentaminoacids,
and we denote the relative frequency of an amino acid a by pa.
Thus, the average information required for specifying an
amino acid is
Iaa ¼ 
X
a
pa log pa bits ð4Þ
When all these frequencies are equal, Iaa¼log220. Otherwise,
the value of Iaa is again smaller.
Owing to the degeneracy of the genetic code which leads to
redundant coding for amino acids, the information needed
to specify an amino acid is smaller than the one contained
in a triplet (log20olog64¼6).
Therefore, when we pass from a coding sequence in the
DNA to the polypeptide that it codes, we see a reduction of
information.
This is the standard application of information theory to
molecular biology, but for applying the concept of the genon,
we need to turn things around. Instead of the backward
perspective where one starts with a polypeptide and
quantiﬁes the uncertainty about the coding sequence in the
DNA or RNA, we start with a genomic domain including
a variety of gene fragments and look at the ensemble of
functional products derived from it (a collection of polypep-
tides or functional RNAs, grouped according to type). As the
case of functional RNA is similar, for simplicity we here only
consider the situation where those functional products are
polypeptides. One such coding domain can be transcribed
and translated several times, and during the expression
process, mechanisms like alternative splicing or translational
frameshift may even lead to chemically different polypep-
tides containing amino acids derived from a single coding
sequence. Thus, we have a single coding domain S at DNA
or RNA level, but an ensemble of products x derived from it.
Let the relative frequency of x in that ensemble be qx.
Therefore, the uncertainty of the result of the expression of
S is given by
IðSÞ¼ 
X
x
qx log qx ð5Þ
The important point we want to make here is that this
information I(S) is not contained in the sequence S, but is
rather provided by the (proto-, pre-)genon that accompanies
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polypeptide it will end up. Therefore,
Igenon :¼ IðSÞð 6Þ
A ﬁner analysis evaluates the information contributed by
the different steps in the regulation of the expression
process. At each step, we have certain binding sites in cis,
and we have certain trans factors that bind or could possibly
bind there. At the transcription and RNA level, we see
mechanisms of transcription activation, RNA processing,
promotion, enhancement or repression. Most of them are
affected by nucleotides outside the coding sequence itself,
but also the coding region can provide speciﬁc protein-
binding sites. Each of these yields information about the
ensemble of products derived from the coding region that is
not contained in the nucleotide sequence information
obeying the genetic code. More precisely, the information
that counts here is not about the identity of a nucleotide or
an amino acid derived from it, but about the relative
frequency of the transcription and generation of a particular
type of coding sequence. This then contributes to the
determination of the types and numbers of functional
products derived from the DNA coding region under
consideration. Whereas the selection of proteins that can
bind at those regulatory sites is determined by the chemical
identity of their nucleotides and therefore represents a
contribution from the genon in cis, the availability or the
relative frequency of different proteins competing for a given
binding site counts as a contribution from the transgenon. At
a later stage, the mechanism of alternative splicing selects
between different compositions of the ﬁnal functional
product. Again, that selection yields a reduction of un-
certainty, that is, an information because before the splicing
process, we do not know which alternative will be chosen.
And that information is provided by the genon because the
number of possibilities cannot be directly read from the
chemical composition of individual nucleotides without
knowing the context. In other words, it is a process and
not a product information. In a similar manner, we can look
at all the different steps in the cascade of regulation.
Whereas nucleotide identities specify a ﬁnal amino-acid
product, on the expression pathway, here the important
information is which proteins or RNAs (in the case of RNAi)
bind to a given mRNA and in which manner they affect the
expression process. Again, this is part of the information
carried by the genon. As before, the presence or absence
of those regulatory proteins or RNAs has to be counted as
information provided by the transgenon.
With our information theoretic analysis, we can also
compare different DNA segments S and   S, where the smaller
segment S is contained in the longer one   S. Here, from the
backward point of view of product information,   S contains
more information when it codes for a longer polypeptide than
S. From our forward analysis of process information, however,
the genon information in   S is higher when the end products
thatcan be derived fromit are fewer,that is,morespeciﬁcthan
the ones derived from the shorter segment S.
As argued, equation (6) expresses the information provided
by the genon, but perhaps not contained in S. Of course, the
genon is at least partly superposed on S. But what, then, is the
information containedinSitselfabouttheendproductderived
from it? It turns out that in the present context, this is
somewhat more arbitrary to specify. The question means to
what extent the possibilities about abstractly possible poly-
peptides are reduced when we know the sequence S. In order
to make this precise and quantiﬁable, we need to select an
ensemble W of polypeptides in which S could possibly be
represented. Here, S is conceived as any coding sequence, that
is, one whose nucleotide composition is unknown. By
determining that composition, we then gain information. But
at this point, we are not interested in that chemical
composition, but in the identity of the possible end products
derived from it. Therefore, determining the nucleotide
composition contributes only indirectly to the information
desired here. Thus, we need to specify the ensemble of
possible end products. This could be the ensemble of all
biochemically possible polypeptides—an astronomical num-
ber—or the ones that can be derived from the genome in
question—about 500000 in the case of the human genome—
or those that actually are made in the given cell—perhaps only
several hundred. Of course, there exist other possible choices.
In any case, within such an ensemble, each polypeptide x has
a relative frequency px and the uncertainty about x then is
IðxÞ¼ 
X
x
px log px ð7Þ
WhenonlyonesinglesuchxcanbederivedfromS,thenthatis
the information contained in S, because this is the amount of
uncertainty deduced about the end product by knowing S. Our
point, however, is that S does not completely specify that end
product, but rather the additional information Igenon from
equation(6)isneeded.Therefore,theinformation providedby
S is only
IðxÞ Igenon ¼ 
X
x
px log px þ
X
x
qx log qx ð8Þ
Accordingto the cascade principle, the choice of ﬁnal products
is divided into multiple steps. Along these steps, the cisgenon
is reduced by RNA processing and the transgenon modiﬁed
according to cell compartment and physiological context. The
relative information from cis and trans can be expressed in
similar terms for each of these steps. The segmentation of this
process facilitates individual selection of products as there is
less uncertainty as the number of possibilities is reduced in
each step.
Conclusion
In conclusion, we have provided an information theoretic
analysis of the information provided by coding sequences and
genons. We have distinguished the sequence information,
determined by the nucleotide or amino-acid frequencies and
thesequencecorrelations,theprocessinformationcontributed
by the genon according to the types and numbers of end
products that can be derived from a given sequence, and the
product information, expressing how much the number of
possibilities for a polypeptide is reduced when we know the
sequence. The difference between the numbers of possibilities
when one does not know or knows the sequence again is the
contribution of the genon. This should facilitate a deeper
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domainsand genons. The condition ‘sine qua non’to carryout
this analysis is to assign a restrictive meaning to the term
‘gene’ and separate this information from the process
information of the genon.
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